Page 3 - Best Liver cancer stage 2 doctors: TOP 91 doctors

Univ. Prof. Dr. Wolfgang Köstler is a distinguished medical oncologist who helped pioneer targeted therapies – a core strategy for treating many liver cancers today.

• Over 22 years of experience of clinical, academic, and research experience in oncology
• Deputy Head of the Clinical Division of Oncology at Medical University of Vienna
• Expertise in individualized systemic therapy and immunotherapy
• Focuses on biomarker development and precision oncology strategies

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers, treating patients at Istinye Liv University Hospital.

• Internal Medicine Specialist with experience at multiple hospitals in Turkey
• Oncologist at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Studied medicine at Selcuk University in Konya
• Promoted to Associate Professor in 2016

Associate Professor Dr. Yusuf Acikgoz brings specialized expertise in Medical Oncology, with training at Ohio State University and active involvement in international clinical trials.

• Participated in Phase III trials like CheckMate-649 and Fortitude-101
• Member of ASCO and Turkish Society of Medical Oncology
• Trained in immuno-oncology through CECOG courses in Vienna
• Certified in Good Clinical Practice and Human Subjects Protection

Professor Keil specializes in diagnostic and interventional radiology, with a focus on liver cancer imaging and interventions at the Academic Hospital Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Trained under renowned Professor Rolf W. Günther in Aachen
• Expert in modern imaging techniques like MRI, CT, and ultrasound
• Chief Physician at the Clinic for Diagnostic and Interventional Radiology since 2022

Chief Physician at a certified interdisciplinary cancer center, Phd Viola Fox specializes in innovative treatments for liver cancer. Her research in molecular biology has advanced cancer therapies.

• Specialized in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics with a focus on oncology
• Active member of the American Association for Cancer Research

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Associate Professor Babek Tabandeh is an expert surgeon specializing in liver cancer and minimally invasive techniques. He performs complex liver surgeries at Medical Park Göztepe Hospital.

• Over of experience in general and cancer surgery
• Focuses on minimally invasive surgery for better recovery
• Published author with 40+ scientific papers
• Member of the prestigious American College of Surgeons
• Also holds membership in the Liver Transplantation Society

Specialized in laparoscopic and oncological cancer surgery with training at Istanbul University. Dr. Al focuses on minimally invasive techniques for liver cancer.

• Trained in advanced laparoscopic surgery at Cerrahpaşa Faculty of Medicine
• Performs laparoscopic bariatric and anti-reflux surgeries
• Graduated from Ondokuz Mayıs University Faculty of Medicine
• Specialized at KTÜ Faculty of Medicine Farabi Hospital

Dr. Ozden brings over 27 years of experience of expertise in oncology, honed through diverse clinical roles across Turkey.

• Specialized in medical oncology with a focus on liver cancer
• Trained at Istanbul University's renowned Cerrahpaşa Faculty of Medicine
• Extensive experience in both private and university hospital settings
• Committed to personalized treatment plans for each patient

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center, bringing 36 years of experience of focused oncology expertise.

• Specializes in Medical Oncology & Radiotherapy
• Head of Gastrointestinal Cancer Center at Hadassah
• Board-certified in Oncology & Radiotherapy
• Member of Israel Society of Clinical Oncology
• Fluent in English and Hebrew for international patients

Assoc. Prof. Nail Paksoy is an ESMO-certified medical oncologist at Medipol Bahçelievler Hospital, specializing in liver cancer with extensive clinical trial experience.

• Completed fellowship at Istanbul University Oncology Institute
• Subinvestigator in 8 international oncology clinical trials
• Published multiple studies on cancer treatment efficacy
• Specializes in personalized treatment approaches

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Specializing in virotherapy – one of the newest immunology fields – Dr. Jaunalksne brings 49 years of experience of experience to liver cancer treatment.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on cutting-edge immunological approaches to cancer

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.